Evaluating System Change to Advance Learning and Take Evidence to Scale (ESCALATES)

Sponsor
Oregon Health and Science University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02560428
Collaborator
University of Texas (Other), Rutgers University (Other), HealthPartners Institute (Other), University of Michigan (Other), Case Western Reserve University (Other)
7
84

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate approximately eight grants that will test interventions to improve cardiovascular disease prevention. The investigators will collect and analyze qualitative data to identify the most effective combinations of intervention strategies. The investigators will observe grantees and selected practices to understand why and how those combinations are effective. The investigators will also gather data from the grantees to assess how effective the interventions are.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ESCALATES

Detailed Description

The purpose of this study is to evaluate approximately eight different R18 grants that will test practice change interventions to improve cardiovascular disease (CVD) prevention screening. The investigators will collect and analyze quantitative data (context, process, and outcomes) to identify the most effective combinations of intervention strategies for various practice types in relation to practice structure, context, and organizational characteristics associated with change in outcomes. The investigators will collect qualitative data (observation, interviews, online diaries) from grantees and selected practices to understand why and how those combinations are effective. The investigators will also gather documents and de-identified quantitative data from grantees.

Evidence clearly shows that many people do not receive guideline-concordant health care; this is true even for low cost treatments such as Aspirin prescribing, Blood pressure and Cholesterol control and Smoking cessation (the ABCS) known to prevent cardiovascular disease (CVD). In hospitals and integrated care systems with substantial resources, large quality improvement campaigns have been shown to increase adherence to guidelines by creating communities of learning that change behavior on a large scale. Agency for Healthcare Research and Quality (AHRQ) and the Patient Centered Outcomes Research Institute (PCORI) are partnering to launch a campaign to promote the improvement of guideline-based CVD preventive care in small primary care practices with limited resources and experience with quality improvement ("Implementation" RFA-HS-14-008). The practices for each of these R18 grants will be in a contiguous geographic region. This study will evaluate each of these R18 implementation grants.

The investigators' strategy is to conduct a prospective observational analysis to evaluate the effectiveness of the R18s ABCS quality improvement initiatives. To do this, the investigators will collect and analyze qualitative data to identify the most effective combinations of intervention strategies for various practice types, contexts, and organizational characteristics, and to understand why and how those combinations are effective. The investigators will also gather de-identified quantitative data that the R18s collected.

Study Design

Study Type:
Observational
Actual Enrollment :
7 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Evaluating System Change to Advance Learning and Take Evidence to Scale (ESCALATES)
Study Start Date :
Apr 1, 2015
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Apr 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Percentage of participants with AMI, coronary artery bypass graft, PCI or IVD, and who had documentation of used of aspirin or another antithrombotic during the measurement period. [Quarterly for 4 years]

    Acute myocardial infarction (AMI), ischemic vascular disease (IVD), percutaneous coronary interventions (PCI)

  2. Percentage of participants with diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90 mmHg) during the measurement period. [Quarterly for 4 years]

  3. Percentage of participants considered at high risk of cardiovascular events who were prescribed or were on a statin therapy during the measurement period. [Quarterly for 4 years]

  4. Percentage of participants who were screened for tobacco use and received cessation counseling intervention if identified as a tobacco user. [Quarterly for 4 years]

Secondary Outcome Measures

  1. Practice capacity for change measured by adaptive reserve (AR) [Baseline, immediately after intervention, 6 months post-intervention (4 years maximum)]

  2. Practice capacity for quality improvement measured by CPCQ [Baseline, immediately after intervention, 6 months post-intervention (4 years maximum)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All R18 grant awardees are included in the study.
Exclusion Criteria:
  • N/A

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Oregon Health and Science University
  • University of Texas
  • Rutgers University
  • HealthPartners Institute
  • University of Michigan
  • Case Western Reserve University

Investigators

  • Principal Investigator: Debbie Cohen, PhD, OHSU, Department of Family Medicine

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Deborah Cohen, Associate Professor, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT02560428
Other Study ID Numbers:
  • 11482
First Posted:
Sep 25, 2015
Last Update Posted:
Sep 28, 2021
Last Verified:
Sep 1, 2021
Keywords provided by Deborah Cohen, Associate Professor, Oregon Health and Science University

Study Results

No Results Posted as of Sep 28, 2021